Tofacitinib citrate and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Tofacitinib citrate (tofacitinib citrate), especially for people who are female, 40-49 old, also take Enbrel, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Atelectasis when taking Tofacitinib citrate. It is created by eHealthMe based on reports of 7,765 people who have side effects when taking Tofacitinib citrate from the FDA, and is updated regularly.

What is Tofacitinib citrate?

Tofacitinib citrate has active ingredients of tofacitinib citrate. eHealthMe is studying from 7,767 Tofacitinib citrate users. Check the latest studies of Tofacitinib citrate.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,434 drugs and 1,638 conditions by eHealthMe. Check the latest studies of Atelectasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

7,765 people reported to have side effects when taking Tofacitinib citrate.
Among them, 69 people (0.89%) have Atelectasis.

Could Tofacitinib citrate cause Atelectasis?

Among these 69 people:

What is the gender of people who have Atelectasis when taking Tofacitinib citrate? *

female: 100 %
male: 0.0 %

What is the age of people who have Atelectasis when taking Tofacitinib citrate? *

What are other drugs people take besides Tofacitinib citrate? *

What are other side effects people have besides Atelectasis? *

Dry Mouth: 69 people, 100.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 69 people, 100.00%
Dry Eyes (lack of adequate tears): 69 people, 100.00%
Synovial Cyst (cyst of joint filled with synovial fluid): 69 people, 100.00%
Interstitial Lung Disease: 69 people, 100.00%
Neoplasm Malignant (cancer tumour): 69 people, 100.00%
Nodule (a growth of abnormal tissue): 69 people, 100.00%
Joint Effusion (presence of extra fluid in joint covering): 69 people, 100.00%
Crepitations (noises are produced by the rubbing of parts one against the other): 69 people, 100.00%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 69 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 69 people, 100.00%
Inflammation: 10 people, 14.49%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 9 people, 13.04%
Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 11.59%
Back Pain: 7 people, 10.14%
Pain: 6 people, 8.70%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 2.90%

* Approximation only. Some reports may have incomplete information.

Do you take Tofacitinib citrate and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tofacitinib citrate:

Tofacitinib citrate (7,767 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Tofacitinib citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,434 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,638 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Tofacitinib citrate) and Tofacitinib citrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.